Endpoint definition
↥| Name | C3_MALE_GENITAL |
|---|---|
| Long name | malignant neoplasm of male genital organs |
| Sex specific endpoint | 1 |
| Include | C3_PENIS, C3_PROSTATE, C3_TESTIS, C3_MALE_GENITAL_NAS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF4 |
malignant neoplasm of male genital organs
male reproductive organ cancer: A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6542 | - | 6542 |
| Unadjusted prevalence (%) | 3.01 | - | 6.95 |
| Mean age at first event (years) | 67.27 | - | 67.27 |
| Case fatality at 5-years (%) | 7.61 | - | 7.61 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | - | 1.0 |
| Recurrence at 6 months (%) | 22.02 | - | 22.06 |
Survival analyses between endpoints
↥Plot
before malignant neoplasm of male genital organs
after malignant neoplasm of male genital organs
Loading survival analyses plot…
Table
Loading survival analyses table…